Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote & News

Company Profile

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma a...

Industry: Biotechnology

Sector: Healthcare

Phone: 508 767 3861

Website: phiopharma.com

Address:

11 Apex Drive, Suite 300A PMB 2006, Marlborough, United States

trader_23 Mar. 1 at 4:22 AM

$PHIO

0 · Reply

Rod75b15 Feb. 26 at 1:07 PM

$PHIO It's just a matter of time—I have no idea if it's a matter of weeks or a few months—but it will return to nearly $9, like in January 2025, when it started at $1.50. Personally, from 2023 to today, I've made excellent profits with Phio several times, and I'm very satisfied with their results and goals.

0 · Reply